Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.32
UNSPSC Code:
12352200
Form:
lyophilized
Assay:
≥95% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in HEK 293 cells
Mol wt:
calculated mol wt 70.6 kDa, observed mol wt 95-110 kDa by SDS-PAGE (reducing) (Glu26 is the predicted N-terminal .)
biological source
human
recombinant
expressed in HEK 293 cells
tag
6-His tagged (C-terminus)
assay
≥95% (SDS-PAGE)
form
lyophilized
mol wt
calculated mol wt 70.6 kDa, observed mol wt 95-110 kDa by SDS-PAGE (reducing) (Glu26 is the predicted N-terminal .)
packaging
pkg of 10 and 50 μg
impurities
<1 EU/μg endotoxin (LAL test)
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... ErbB4(2066)
General description
Receptor tyrosine-protein kinase erbB-4 (ErbB4), also known as Her4, is a single-pass type I transmembrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors. ErbB4 is expressed in normal skeletal muscle, heart, pituitary, brain and several breast carcinomas. ERBB4 contains multiple furin-like cysteine rich domains, a tyrosine kinase domain, a phosphatidylinositol-3 kinase binding site and a PDZ domain binding motif. The gene encoding this protein is localized on human chromosome 2q34.
Biochem/physiol Actions
Receptor tyrosine-protein kinase erbB-4 (ErbB4) binds to and is activated by neuregulins-2 and -3, heparin-binding EGF-like growth factor and β-cellulin. Ligand binding induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. ErbB4 appears to play important roles in neuronal development, development of the heart and cancer. Mutations in this gene have been associated with cancer. Other single-nucleotide polymorphisms and a risk haplotype have been linked to schizophrenia.
Physical form
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Generally 5-8% Mannitol or trehalose is added as a protectant before lyophilization.
Preparation Note
Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 μg/mL. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Ligand-specifi'c activation of HER4/pl80erbB4, a fourth member of
the epidermal growth factor receptor family
the epidermal growth factor receptor family
Gregory D. Plowman
Proceedings of the National Academy of Sciences of the USA, 90, 1746-1750 (1993)
A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study
Hyung-cheol Kim
Breast Cancer Research, 14, R56-R56 (2012)
The epidermal growth factor receptor family
L A Bazley and W J Gullick
Endocrine-Related Cancer, S17-S27 (2005)
ERBB4 Expression in Ovarian Serous Carcinoma Resistant to
Platinum-Based Therapy
Platinum-Based Therapy
Ozlen Saglam
Cancer Control : Journal of the Moffitt Cancer Center, 24(1), 89-95 (2017)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service